Document ID: chunk:federal_register_of_legislation:C2023A00008:clause:2_14
Version: federal_register_of_legislation:C2023A00008
Segment Type: clause
Provision Reference: sch 2 cl 14
Character Range: 18205–19292

14  Transitional provisions—ongoing listing fees imposed before commencement time
(1) This item applies if:
 (a) immediately before the commencement time, an ongoing listing fee is due and payable in respect of a kind of prosthesis; and
 (b) after the commencement time, the kind of prosthesis is listed as a kind of medical device or human tissue product in the Private Health Insurance (Medical Devices and Human Tissue Products) Rules.
(2) Subsection 72‑20(2) of the amended Act has effect, in relation to that kind of medical device or human tissue product, as if:
 (a) a reference in that subsection to medical devices and human tissue products levy in respect of the ongoing listing of the kind of medical device or human tissue product included a reference to the ongoing listing fee; and
 (b) the reference in paragraph (b) of that subsection to the Private Health Insurance (Levy Administration) Rules were, in relation to the ongoing listing fee, a reference to subsection 72‑15(2) of the Private Health Insurance Act 2007 as in force immediately before the commencement time.